Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s Net Profit Rose 25.2% in First Three Quarters of 2022

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (浙江莎普爱思药业股份有限公司) (603168.SH) reported a net profit of 45.3 million yuan in the first three quarters of 2022, up 25.2% year-on-year.

Meanwhile, the company posted 414.4 million yuan in revenue, down 12.4% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 153.9 million yuan in total liabilities, with a liability-to-asset ratio of 9.9%.